Restructuring, Impairment and Other Charges (Tables)

9 Months Ended

Sep. 30, 2013

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

The following table summarizes the impact of the Company’s restructuring charges (accrual adjustments) on the condensed consolidated statements of operations:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2013		2012			2013		2012
Cost of sales – services	$	2,124	$	956		$	8,983	$	91
Cost of sales – products	212		(2,064		)	429		(1,959		)
Selling and administrative expense	1,859		2,454			9,375		5,654
Research, development and engineering expense	151		1,116			2,617		1,116
Total	$	4,346	$	2,462		$	21,404	$	4,902

Restructuring charges (accrual adjustments) within continuing operations for DNA and DI reporting segments

The following table summarizes the Company’s net restructuring charges for its Diebold North America (DNA) and DI reporting segments:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2013		2012			2013		2012
DNA
Severance	$	962	$	3,313		$	14,373	$	4,870
Other	224		—			224		—
DI
Severance	2,827		(621		)	6,334		(329		)
Other	333		(230		)	473		361
Total	$	4,346	$	2,462		$	21,404	$	4,902

Restructuring accrual balances and related activity

The following table summarizes the Company’s restructuring accrual balances:

	2013			2012
Balance at January 1	$	11,844		$	10,136
Liabilities incurred	21,404			4,902
Liabilities paid	(27,239		)	(5,347		)
Balance at September 30	$	6,009		$	9,691